Recommendation ID
IPG490/1
Question
NICE encourages further research into transcutaneous neuromuscular electrical stimulation (NMES) for oropharyngeal dysphagia, which should clearly document the indications for treatment and the details of patient selection. Research should document the timing of initiation of treatment after onset of symptoms, as well as precise information about the procedure technique. Outcome measures should include freedom from tube feeding, quality of life and duration of treatment effect. NICE may review the procedure on publication of further evidence.
Any explanatory notes
(if applicable)
Current evidence on the efficacy of transcutaneous neuromuscular electrical stimulation (NMES) for oropharyngeal dysphagia is limited in quality. The evidence on safety is limited in both quality and quantity but there were no major safety concerns. Therefore, this procedure should only be used with special arrangements for clinical governance, consent and audit or research.

Source guidance details

Comes from guidance
Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia
Number
IPG490
Date issued
May 2014

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 27/06/2014